Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Orphenadrine 50mg/5ml oral solution sugar free
0409020N0AAALAL
|
Orphenadrine hydrochloride | Orphenadrine hydrochloride | Central Nervous System | 1,531 |
|
Orphenadrine 50mg tablets
0409020N0AAAMAM
|
Orphenadrine hydrochloride | Orphenadrine hydrochloride | Central Nervous System | 133 |
|
Orphenadrine 25mg/5ml oral solution
0409020N0AAAKAK
|
Orphenadrine hydrochloride | Orphenadrine hydrochloride | Central Nervous System | No data available |
|
Orphenadrine 25mg/5ml oral solution sugar free
0409020N0AAABAB
|
Orphenadrine hydrochloride | Orphenadrine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.